Plovanic William J. 4
4 · OBALON THERAPEUTICS INC · Filed Jan 28, 2020
Insider Transaction Report
Form 4
Plovanic William J.
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2020-01-24+441,125→ 441,125 total→ Common Stock (441,125 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.